Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We identified the multifunctional chaperon protein
p32
as a protein kinase C (PKC)-binding protein interacting with PKCalpha, PKCzeta, PKCdelta, and PKC mu. We have analyzed the interaction of PKC mu with
p32
in detail, and we show here in vivo association of PKC mu, as revealed from yeast two-hybrid analysis, precipitation assays using glutathione S-transferase fusion proteins, and reciprocal coimmunoprecipitation. In SKW 6.4 cells, PKC mu is constitutively associated with
p32
at mitochondrial membranes, evident from colocalization with cytochrome c.
p32
interacts with PKC mu in a compartment-specific manner, as it can be coimmunoprecipitated mainly from the particulate and not from the soluble fraction, despite the presence of
p32
in both fractions. Although
p32
binds to the kinase domain of PKC mu, it does not serve as a substrate. Interestingly, PKC mu-
p32
immunocomplexes precipitated from the particulate fraction of two distinct cell lines, SKW 6.4 and 293T, show no detectable substrate phosphorylation. In support of a kinase regulatory function of
p32
, addition of
p32
to in vitro kinase assays blocked, in a dose-dependent manner,
aldolase
but not autophosphorylation of PKC mu, suggesting a steric hindrance of substrate within the kinase domain. Together, these findings identify
p32
as a novel, compartment-specific regulator of PKC mu kinase activity.
...
PMID:Protein kinase C [micro] is regulated by the multifunctional chaperon protein p32. 1083 94